VGluT3 BNST neurons transmit GABA and restrict feeding without affecting rewarding or aversive processing
Annie Ly,
No information about this author
Rachel Karnosky,
No information about this author
Emily D. Prévost
No information about this author
et al.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 2, 2025
The
bed
nucleus
of
the
stria
terminalis
(BNST)
is
involved
in
feeding,
reward,
aversion,
and
anxiety-like
behavior.
We
identify
BNST
neurons
defined
by
expression
vesicular
glutamate
transporter
3,
VGluT3.
VGluT3
were
localized
to
anteromedial
BNST,
molecularly
distinct
from
accumbal
neurons,
co-express
GABA
(VGaT).
Cell-type
specific
presynaptic
processes
identified
arcuate
(ARC)
paraventricular
hypothalamus
(PVN),
regions
critical
for
feeding
homeostatic
regulation.
Whole-cell
patch-clamp
electrophysiology
revealed
that,
while
these
VGaT,
they
functionally
transmit
both
ARC
PVN,
with
rare
co-transmission
ARC.
Neuronal
recordings
showed
greater
calcium-dependent
signaling
response
sucrose
consumption
sated
compared
fasted.
When
fasted,
optogenetic
stimulation
decreased
using
several
conditions
but
not
when
occurred
prior
access,
suggesting
that
activation
concurrent
fasted
state
reduces
feeding.
during
paradigms
(novelty-suppressed
open
field,
elevated
zero
maze)
real-time
place
conditioning
resulted
no
changes
or
reward/aversion
interpret
data
such
represent
a
unique
cellular
population
within
provides
inhibitory
input
hypothalamic
decrease
without
affecting
Language: Английский
GABAB receptor-mediated potentiation of ventral medial habenula glutamatergic transmission in GABAergic and glutamatergic interpeduncular nucleus neurons
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 3, 2025
Abstract
The
medial
habenula
(MHb)-interpeduncular
nucleus
(IPN)
pathway
plays
an
important
role
in
information
transferring
between
the
forebrain
and
midbrain.
MHb-IPN
has
been
implicated
regulation
of
fear
behavior
nicotine
addiction.
synapses
ventral
MHb
IPN
show
a
unique
property,
i.e.,
enhancement
synaptic
transmission
upon
activation
GABA
B
receptors.
This
receptor-mediated
potentiation
regulating
memory.
Although
is
known
to
contain
parvalbumin
(PV)
somatostatin
(SST)
GABAergic
neurons
vesicular
glutamate
transporter
3
(VGLUT3)-expressing
neurons,
it
unknown
how
receptor
affects
MHb-mediated
glutamatergic
onto
these
three
subtypes
neurons.
Our
studies
robust
connectivity
from
PV
SST
IPN,
while
VGLUT3
weak.
receptors
produces
we
observed
modest
effect
Despite
diminished
basal
causes
transient
conversion
non-responding
into
active
some
Thus,
our
results
strong
compared
VGLUT3-expressing
Furthermore,
differential
on
PV,
SST,
IPN.
Language: Английский
Deciphering the Functions of Raphe–Hippocampal Serotonergic and Glutamatergic Circuits and their Deficits in Alzheimer’s Disease
Wanting Yu,
No information about this author
R Zhang,
No information about this author
Aosheng Zhang
No information about this author
et al.
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(3), P. 1234 - 1234
Published: Jan. 30, 2025
Subcortical
innervation
of
the
hippocampus
by
raphe
nucleus
is
essential
for
emotional
and
cognitive
control.
The
two
major
afferents
from
to
originate
serotonergic
glutamatergic
neurons,
which
control
hippocampal
inhibitory
network,
theta
activity,
synaptic
plasticity
have
been
extensively
explored
in
growing
body
literature,
whereas
those
circuits
received
little
attention.
Notably,
both
between
are
disrupted
Alzheimer's
disease
(AD),
may
contribute
initiation
progression
behavioral
psychological
symptoms
dementia.
Thus,
deciphering
mechanism
underlying
abnormal
raphe-hippocampal
AD
crucial
prevent
dementia-associated
symptoms.
In
this
review,
we
summarize
anatomical,
neurochemical,
electrophysiological
diversity
nuclei
as
well
architecture
circuitry.
We
then
elucidate
subcortical
activity
their
role
regulation
emotion
cognition.
Additionally,
present
an
overview
pathogenesis
analyze
available
therapies
that
can
potentially
be
used
clinically
alleviate
neuropsychiatric
decline
course.
Language: Английский